Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vijayakumar, S.
Right arrow Articles by Sutton, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vijayakumar, S.
Right arrow Articles by Sutton, H. G.

Radiology, Vol 184, 271-274, Copyright © 1992 by Radiological Society of North America

ARTICLES

Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy

S Vijayakumar, SF Quadri, TG Karrison, CO Trinidad, SK Chan, HJ Halpern, SJ Rubin and HG Sutton
Department of Radiation Oncology, Humana Hospital-Michael Reese, Chicago, IL 60616.

The serum half-life of prostate-specific antigen (PSA) after radical prostatectomy is about 3 days; to the authors' knowledge, the PSA half- life during radiation therapy (RT) has not been investigated with weekly serial measurements. To determine the rate of decline and the half-life of PSA, serial measurements were obtained during 6-8 weeks of external-beam RT for localized prostate cancer. PSA values were determined immediately before and approximately 24 hours after the first dose of RT; thereafter, weekly measurements were made. There was a downward trend in PSA levels in 19 patients, with a median half-life of 58.5 days; the mean decline was 1.6% per day. However, in four patients, PSA levels either rose and fell to pre-RT values or increased steadily. The effect of digital rectal examination (DRE) on PSA levels was also analyzed. When the dates of DRE and subsequent PSA levels were inspected, no increase in PSA levels subsequent to DRE was found, although three of the four patients in whom PSA levels did not decrease underwent multiple DREs. The authors found a statistically significant (P = .023) transient elevation in the mean PSA values after the first fraction of RT (2 Gy) was administered; the mechanism and importance of which are not known.


This article has been cited by other articles:


Home page
 JCOHome page
P. P. Connell, L. Ignacio, D. Haraf, A. M. Awan, H. Halpern, I. Abdalla, J. Nautiyal, A. B. Jani, R. R. Weichselbaum, and S. Vijayakumar
Equivalent Racial Outcome After Conformal Radiotherapy for Prostate Cancer: A Single Departmental Experience
J. Clin. Oncol., January 1, 2001; 19(1): 54 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. C. Hartford, T. Gohongi, D. Fukumura, and R. K. Jain
Irradiation of a Primary Tumor, Unlike Surgical Removal, Enhances Angiogenesis Suppression at a Distal Site: Potential Role of Host-Tumor Interaction
Cancer Res., April 1, 2000; 60(8): 2128 - 2131.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
J.-M. Bidart, F. Thuillier, C. Augereau, J. Chalas, A. Daver, N. Jacob, F. Labrousse, and H. Voitot
Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
Clin. Chem., October 1, 1999; 45(10): 1695 - 1707.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.